(Q57306224)

Heli Nevanlinna

6

0 references

Lauri Aaltonen

Lauri A Aaltonen

7

0 references

Carl Blomqvist

5

Carl Blomqvist

0 references

Hannaleena Eerola

3

Hannaleena Eerola

0 references

Virpi Launonen

8

Virpi Launonen

0 references

Kristiina Aittomäki

4

Kristiina Aittomäki

0 references

author name string

Maija Kiuru

European Journal of Human Genetics

1

0 references

publication date

3 November 2004

0 references

published in

0 references

volume

13

0 references

issue

4

0 references

page(s)

506-509

0 references

cites work

Inherited susceptibility to uterine leiomyomas and renal cell cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201326

Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201326

Localization of a gene (MCUL1) for multiple cutaneous leiomyomata and uterine fibroids to chromosome 1q42.3-q43.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201326

Familial cutaneous leiomyomatosis is a two-hit condition associated with renal cell cancer of characteristic histopathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201326

Mutations in the fumarate hydratase gene cause hereditary leiomyomatosis and renal cell cancer in families in North America

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201326

Germline Fumarate Hydratase Mutations in Families with Multiple Cutaneous and Uterine Leiomyomata

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201326

Germline mutations in fumarate hydratase (FH) do not predispose to prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201326

No fumarate hydratase (FH) mutations in hereditary prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201326

A probability model for predicting BRCA1 and BRCA2 mutations in breast and breast-ovarian cancer families

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201326

Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201326

Somatic deletions in hereditary breast cancers implicate 13q21 as a putative novel breast cancer susceptibility locus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201326

Genome-wide scanning for linkage in Finnish breast cancer families

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201326

Familial breast cancer in southern Finland

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201326

Low proportion of BRCA1 and BRCA2 mutations in Finnish breast cancer families: evidence for additional susceptibility genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201326

Biallelic inactivation of fumarate hydratase (FH) occurs in nonsyndromic uterine leiomyomas but is rare in other tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201326

Denaturing high-performance liquid chromatography: A review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201326

Genetic and functional analyses of FH mutations in multiple cutaneous and uterine leiomyomatosis, hereditary leiomyomatosis and renal cancer, and fumarate hydratase deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201326

inferred from DOI database lookup

7 January 2021

based on heuristic

Strong indication for a breast cancer susceptibility gene on chromosome 8p12-p22: linkage analysis in German breast cancer families

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201326